P242 CZP improves work and household productivity and social participation over 1 year of treatment in patients with non-radiographic axSpA
Abstract
Background Certolizumab pegol (CZP) treatment has been shown to significantly improve work and household productivity and social participation compared to placebo in active non-radiographic axial spondyloarthritis (nr-axSpA) patients up to 24 weeks. Here, we report the impact of CZP in combination with non-biologic background medication (NBBM) on signs and symptoms of nr-axSpA compared to placebo+NBBM. Methods C-axSpAnd (NCT02552212) is a...
Paper Details
Title
P242 CZP improves work and household productivity and social participation over 1 year of treatment in patients with non-radiographic axSpA
Published Date
Apr 1, 2020
Journal
Volume
59
Issue
Supplement_2
Citation AnalysisPro
You’ll need to upgrade your plan to Pro
Looking to understand the true influence of a researcher’s work across journals & affiliations?
- Scinapse’s Top 10 Citation Journals & Affiliations graph reveals the quality and authenticity of citations received by a paper.
- Discover whether citations have been inflated due to self-citations, or if citations include institutional bias.
Notes
History